Revivicor is a regenerative medicine company focused on applying leading-edge animal biotechnology platforms to provide a superior quality, high-volume, human-compatible, alternative tissue source for treatment of human degenerative disease.

XenoTherapeutics is a clinical-stage cell and gene therapy company engineering immune-compatible cells, tissues, and organs. XenoTherapeutics conducts all phases of clinical product development, from initial genome engineering to prototype design, from manufacturing to clinical evaluation. We Engineer Life. In 2019, XenoTherapeutics successfully completed the first ever FDA-cleared genetically engineered non-human organ transplant for investigational use.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

AxoGen, Inc. engages in the development of treatment options for the repair of peripheral nerve injuries. It offers AVANCE Nerve Graft, a human allograft nerve that is used for the repair, replacement, and reconstruction of damaged peripheral nerves. The company accepts orders through phone, fax, or email. It serves surgeons. AxoGen has a strategic tissue recovery partnership with American Tissue Services Foundation (ATSF). The company was founded in 2002 and is based in Alachua, Florida.

Hangzhou Qihan Biotech Co., Ltd. (doing business as Qihan Biotech) is a Chinese company located in Hangzhou that provides healthcare services. It was founded in 2017 by George McDonald Church and Luhan Yang. Luhan Yang has been the CEO since the inception date.\nThe company says this about itself: Qihan Biotech is a biotech company applying genome-editing technology to develop novel cell therapies and organs for transplantation. The company's mission is to use high- throughput, multiplexable genome editing combined with expertise in transplantation immunology to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. With a vision to create a world in which cell and organ therapies are universally available to patients, Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. Qihan Biotech is headquartered in Hangzhou, China.

Alexis Bio LLC operates as a clinical-stage biotechnology company. It develops a platform focused on immunogenomic reprogramming of live foreign cells from other species for the purpose of transplanting tissues and organs into human patients. The company was founded by Paul Holzer and Jon Adkins in 2019 and is headquartered in Enfield, NH.

Taian Qihang Biotechnology Co., Ltd., established on 2017-04-25, The scope of business includes engaging in biological,medicine,Technology development in the field of science and technology,consult,Serve,Production,Sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Tutogen Medical GmbH is a German company located in Neunkirchen am Brand that manufactures medical apparatus. Stefan Puskeppelies is currently the CEO of the firm.

Optipharm provides a biomedical solution that is involved in the development of cell therapy products using animal stem cells. The company was founded in July 2000 as Avicore Biotechnology Research Center and merged with Medipig Korea and Optipharm Solution Center in December 2007, after which it was renamed Optipharm Solution. It entered the veterinary medicine field in April 2008 by acquiring Farmscare, and it was listed on the KOSDAQ in October 2018 after the company's name was changed to its current name Optipharm in September 2012. It is currently involved in the business of animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, and so on, and it is expanding into the field of human medicine based on the technology that it has accumulated in the field of animal medicine.

Part of MOH Holdings Pte Ltd., Singapore Health Services Pte Ltd. is a Singaporean company located in Singapore. The firm provides medical services. Ivy Ng is the CEO, in this role since 2012.

Agennix AG is a publicly traded biopharmaceutical company that is developing novel therapies in areas of major unmet medical need to improve the length and quality of life of seriously ill patients. The Company's most advanced program is talactoferrin, an oral targeted therapy that has demonstrated activity in randomized, double-blind, placebo-controlled Phase 2 studies in non-small cell lung cancer as well as in severe sepsis. Talactoferrin is currently in Phase 3 clinical trials in non-small cell lung cancer. Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1 testing; the oral platinum-based compound satraplatin; and a topical gel form of talactoferrin for diabetic foot ulcers. Agennix's registered seat is in Heidelberg, Germany. The Company has three sites of operation: Martinsried/Munich, Germany; Princeton, New Jersey and Houston, Texas.

LMT LLC provides massage therapy services. The company was founded in 2015 and is headquartered in Portland, OR.

Bergonie Institute is a cancer treatment center. They provide treatment for the spine, digestive system, genetics, gynecology, hematology, ENT, sarcomas, breast, the nervous system, thorax, thyroid, and urology. They also provide supportive oncological care and support that can be offered to a person suffering from a cancerous pathology. This includes specific treatments intended to cure their disease, such as chemotherapy, radiotherapy, and surgery.